NextGen Sciences | GenomeWeb

NextGen Sciences

Start-up biotech firm Molecular Metabolism has purchased the assets of NextGen Sciences' diagnostics subsidiary.

NextGen Sciences has entered default in a suit filed by six former employees alleging that the company and its officers Leif Hamoe and Thomas Borcholte failed to pay them wages owed for the period Aug. 1, 2012, through Oct.

Former employees of protein biomarker discovery firm NextGen Sciences have sued the company for failing to pay compensation they claim is owed them.

NextGen Group has announced that due to an inability to secure additional financing it will likely take steps to wind down its business unless it is able in the near future to find a buyer for its principal subsidiary, protein biomarker firm NextGen Sciences.

A research team led by scientists at Boston University has identified several RNA-binding proteins as potential therapeutic targets and biomarkers for neurodegenerative diseases including Alzheimer's.

NextGen Sciences this week launched its CSFassay-rat A.1.0 assay for the discovery and quantification in rats of protein biomarkers linked to central nervous system disorders including dementia and Parkinson's.

Aushon Biosystems announced this week its plans to launch a new multiplex protein biomarker platform.

NextGen Sciences this week introduced its PLASMAssay-human A.1.0 protein biomarker discovery panel.
The panel uses selected-reaction monitoring mass spectrometry to simultaneously measure levels of 52 plasma proteins.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – UK-based NextGen Group announced this week it has completed the formation of a diagnostics subsidiary to develop tests for central nervous system disorders.

NextGen Sciences this week launched its csfdiscovery 82 multiplex protein assay for the discovery and quantification of protein biomarkers linked to central nervous system diseases including Alzheimer's, Parkinson's, and multiple sclerosis.

Pages

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.